Exome Asset Management LLC Portfolio Holdings

Exome Asset Management LLC

  • $165 Billion
  • Q3 2025

Exome Asset Management LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $165 Billion distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ionis Pharmaceuticals Inc with a value of $8.57B, Cytokinetics Inc with a value of $7.83B, Bridge Bio Pharma, Inc. with a value of $6.91B, Cogent Biosciences, Inc. with a value of $6.37B, and Guardant Health, Inc. with a value of $6.13B.

Examining the 13F form we can see an increase of $30.6B in the current position value, from $135B to 165B.

Exome Asset Management LLC is based out at New York, NY

Below you can find more details about Exome Asset Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $165 Billion
Healthcare: $123 Billion
ETFs: $2.71 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $165 Billion
  • Prior Value $135 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 21 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email